Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors.
Pathological grade is a useful prognostic factor for stratifying breast cancer patients into favorable (well-differentiated tumors) and less favorable (poorly-differentiated tumors) outcome groups. The current system of tumor grading, however, is subjective and a large proportion of tumors are characterized as intermediate-grade tumors, making determination of optimal treatments difficult. To determine whether molecular profiles can discriminate breast disease by grade, patterns and levels of allelic imbalance (AI) at 26 chromosomal regions frequently altered in breast disease were examined in 185 laser microdissected specimens representing well-differentiated (grade 1; n = 55), moderately-differentiated (grade 2; n = 71), and poorly-differentiated (grade 3; n = 59) stage I-IV breast tumors. Overall levels of AI were significantly higher in grade 3 compared to grade 1 tumors (P < 0.05). Grades 1 and 3 showed distinct genetic profiles--grade 1 tumors were associated with large deletions of chromosome 16q22, while alterations at 9p21, 11q23, 13q14, 17p13.1 and 17q12 were characteristics of grade 3 carcinomas. In general, levels and patterns of AI in grade 2 carcinomas were intermediate between grade 1 and grade 3 tumors. Patterns of AI accurately categorized approximately 70% of samples into high- or low-grade disease groups, suggesting that the majority of breast tumors have genetic profiles consistent with high- or low-grade, and that molecular signatures of breast tumors can be useful for more accurate characterization of invasive breast cancer.
Ellsworth
Rachel E
RE
Clinical Breast Care Project, Windber Research Institute, Windber, PA, USA. r.ellsworth@wriwindber.org
Hooke
Jeffrey A
JA
Love
Brad
B
Kane
Jennifer L
JL
Patney
Heather L
HL
Ellsworth
Darrell L
DL
Shriver
Craig D
CD
D022981:Allelic Imbalance; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D002277:Carcinoma / Q000235:genetics; D002454:Cell Differentiation; D002874:Chromosome Mapping; D005260:Female; D042822:Genomic Instability; D006801:Humans; D018895:Microsatellite Repeats; D009361:Neoplasm Invasiveness; D020161:Physical Chromosome Mapping; D017698:Postmenopause; D017697:Premenopause; D011379:Prognosis; D016896:Treatment Outcome